Status and phase
Conditions
Treatments
About
Study of NGM120 in subjects with advanced solid tumors and and pancreatic cancer (Part 1 and 2) and metastatic castration resistant prostate cancer (Part 3).
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria (Part 1 and 2):
Inclusion Criteria (Part 3 Prostate Cancer):
Exclusion Criteria (All parts):
Primary purpose
Allocation
Interventional model
Masking
90 participants in 7 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal